<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Clostridium difficile toxin A (TcdA) is one of the main pathogenic factors released by C. difficile </plain></SENT>
<SENT sid="1" pm="."><plain>Due to its potent cytotoxic and proinflammatory activities, we investigated the anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> activity of TcdA </plain></SENT>
<SENT sid="2" pm="."><plain>CT26 <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells were challenged with recombinant TcdA, and it was found that TcdA could induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of CT26 cells </plain></SENT>
<SENT sid="3" pm="."><plain>Calreticulin (CRT) exposure to the cell surface during TcdA-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> suggested that this <z:mpath ids='MPATH_3'>apoptosis</z:mpath> may correlate with immunogenicity </plain></SENT>
<SENT sid="4" pm="."><plain>Moreover, TcdA-treated apoptotic CT26 cells were highly immunogenic since they could stimulate DC activation, T-cell activation, and anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> activity </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, the anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> immune response generated was specific and long-term </plain></SENT>
<SENT sid="6" pm="."><plain>In summary, these studies demonstrate that C. difficile toxin A can induce apoptotic <z:hpo ids='HP_0011420'>death</z:hpo> of CT26 <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells and stimulate potent anti-<z:e sem="disease" ids="C1519680" disease_type="Disease or Syndrome" abbrv="">tumor immunity</z:e> </plain></SENT>
</text></document>